Source Capital Recapitalizes CTL Amedica

May 1, 2021

Source Capital, through its Source Capital Credit Opportunities Fund III (SCCO III), provided debt financing to recapitalize and supply growth funding for CTL Amedica, a designer, manufacturer and distributor of spinal fusion and fixation products. The financing will support CTL Amedica's product-portfolio expansion—including its silicon nitride spinal implants—and ongoing commercialization to surgeons and healthcare providers across the U.S.

Buyers
Source Capital (Source Capital Credit Opportunities Fund III, LP)
Targets
CTL Amedica
Industry
Medical Devices
Location
Texas, United States
Transaction Type
Recapitalization

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.